Welcome to our dedicated page for Novanta news (Ticker: NOVT), a resource for investors and traders seeking the latest updates and insights on Novanta stock.
Novanta Inc. (Nasdaq: NOVT) is a global supplier of core technology solutions for medical, life science, and advanced industrial original equipment manufacturers. As a trusted technology partner to medical and advanced technology equipment manufacturers, the company frequently features in news related to its financial performance, capital markets activity, and participation in investor and industry conferences.
News about Novanta often includes quarterly earnings releases and related conference call announcements, where the company reports GAAP results alongside non-GAAP metrics such as Adjusted EBITDA, Adjusted Diluted EPS, and Organic Revenue Growth. These updates provide insight into how its precision medicine, precision manufacturing, medical solutions, robotics and automation, and advanced surgery businesses are performing.
Investors can also expect coverage of capital structure developments, such as the offering and pricing of tangible equity units that combine prepaid stock purchase contracts with senior amortizing notes, as well as amendments to credit agreements and details of senior credit facilities. Announcements about share repurchase authorizations by the Board of Directors are another recurring news theme, reflecting decisions on capital allocation.
In addition, Novanta regularly appears in conference and investor event schedules, including healthcare and industrial conferences hosted by firms such as J.P. Morgan, Baird, Jefferies, and CJS Securities. These events highlight management’s engagement with the investment community and provide forums for discussing strategy and market positioning.
This news page aggregates such items in one place, helping readers follow Novanta’s earnings announcements, financing activities, share repurchase plans, and public presentations over time.
Novanta Inc. (NASDAQ: NOVT) will release its fourth quarter and full year 2021 results on March 01, 2022, followed by a conference call at 10:00 a.m. ET. Investors can join the call by dialing (888) 346-3959 or via live webcast on Novanta's website. A replay will be available three hours post-call, accessible until April 04, 2022. Novanta specializes in technology solutions for healthcare and advanced industrial OEMs, focusing on photonics, vision, and precision motion to provide competitive advantages.
Novanta Inc. (NASDAQ: NOVT) announced that Chief Financial Officer Robert Buckley and Executive Vice President Charlie Webster will present at the CJS Securities 22nd Annual New Ideas for the New Year Investor Conference on Wednesday, January 12, 2022. Novanta is a leading global supplier of technology solutions for medical and advanced industrial OEMs, focusing on photonics, vision, and precision motion. The company's innovative team drives its success by addressing complex technical challenges, enhancing performance and precision in applications.
Novanta Inc. (NASDAQ:NOVT) announced that Matthijs Glastra, Chairperson and CEO, along with CFO Robert Buckley, will present at the J.P. Morgan Healthcare Conference on January 11, 2022, in San Francisco, California. As a leading global supplier of core technology solutions, Novanta enables medical and advanced industrial OEMs to achieve a competitive advantage through its expertise in photonics, vision, and precision motion. The company focuses on delivering high-performance components tailored to demanding applications, driven by a commitment to innovation and customer success.
Novanta Inc. reported strong Q3 2021 results, achieving GAAP revenue of $177.7 million, a 24.3% increase from Q3 2020. GAAP net income reached $14 million, with diluted EPS of $0.38. Adjusted diluted EPS rose to $0.75, reflecting robust demand in advanced industrial and medical sectors. Notably, bookings surged 84% year-over-year. The company raised its 2021 revenue guidance to between $693 million and $703 million, expecting fourth quarter revenue of $185 million to $195 million, illustrating strong market momentum despite ongoing supply chain challenges.
Novanta Inc. (Nasdaq: NOVT) announced that CEO Matthijs Glastra and CFO Robert Buckley will present at Baird's 2021 Global Industrial Conference on November 10, 2021. The conference will be held virtually. Novanta is recognized for providing advanced technology solutions to medical and industrial OEMs, enabling them to achieve competitive advantages through precision and performance. Their expertise lies in photonics, vision, and precision motion technologies. For more information, visit www.novanta.com.
Novanta Inc. (Nasdaq: NOVT) is set to release its third quarter 2021 financial results on November 09, 2021. The company will also host a conference call at 10:00 a.m. ET on the same day to discuss these results. Interested parties can join the call by dialing (888) 346-3959 or through a live webcast on the company’s website. A replay will be available three hours post-call until January 03, 2022.
Novanta provides advanced technology solutions aimed at enhancing the competitive edge of healthcare and industrial OEMs.
Novanta Inc. (NASDAQ: NOVT) announced that CEO Matthijs Glastra and CFO Robert Buckley will present at Baird's 2021 Global Healthcare Conference on September 15, 2021. This virtual event focuses on the company's role as a technology partner to medical and advanced technology OEMs, showcasing its expertise in photonics, vision, and precision motion. Novanta's solutions provide competitive advantages through tailored components that meet demanding applications. The company emphasizes innovation and customer success as core drivers of its growth.
Novanta Inc. (NASDAQ: NOVT) has successfully completed the acquisitions of Schneider Electric Motion USA Inc. (SEM) and ATI Industrial Automation Inc. (ATI). These strategic acquisitions are set to enhance Novanta’s capabilities in the precision motion and robotics sectors. The Company has also updated its financial guidance for 2021, expecting GAAP revenue between $685 million and $700 million, with Adjusted EBITDA ranging from $145 million to $148 million, and Adjusted Diluted EPS between $2.40 and $2.50.
Novanta reported strong financial results for Q2 2021, achieving GAAP revenue of $167.5 million, up 15.8% from Q2 2020. Bookings soared 77% year-over-year, highlighting robust customer demand. Operating income rose to $16.0 million, while adjusted diluted EPS increased to $0.62 from $0.48. The company expects continued growth, projecting Q3 revenue between $165 million and $170 million and full-year revenue of $660 million to $670 million. Future growth is anticipated from pending acquisitions of ATI and SEM.
Novanta Inc. (NASDAQ: NOVT) has agreed to acquire ATI Industrial Automation for $172 million in cash, with additional contingent payments based on ATI's 2021 performance. ATI specializes in intelligent end-of-arm technology solutions for robotics in industrial and medical applications, expecting over $70 million in revenue for 2021. The acquisition aims to enhance Novanta's position in robotics, particularly in electric vehicles and medical sectors, creating a $250 million Precision Motion Segment. The deal is expected to close in Q3 2021 and to be accretive to Novanta's earnings.
FAQ
What is the current stock price of Novanta (NOVT)?
What is the market cap of Novanta (NOVT)?
